At Nano Biotherapeutics, our mission is to treat acute and chronic inflammation and tissue injury in the heart and lungs using albumin nanoparticle mediated drug delivery.


Our nano drug platform is based on albumin, a natural protein, and our nanoparticle can entrap small hydophobic drugs. We load it with an anti-inflammatory drug to target activated neutrophils, which accumulates at the site of injury. Then, the released drug suppresses inflammation.

Therapeutic Advantages

1

Distinct

Our technology is an adjunct therapy

first to be administered, followed by

current clinical practice. All companies

with market presence are potential

strategic partners.

2

No Adverse Side Effects

Our technology neutralizes activated neutrophils without affecting host's ability to mount immune response.

3

Significant Cost Savings

Costs significantly lower than current antibodies & protein therapeutics, as drug prep involves few steps and raw materials are relatively inexpensive.

Follow for Updates


Whether you are a scientist, investor or just curious, subscribe to stay informed on the latest news.

Field is required Incorrect email
Field is required Incorrect email
Field is required Incorrect email
You have successfully subscribed.
You were not subscribed. Please try again.
You are already subscribed.
Sign Up!